# ESCITALOPRAM OXALATE
> **ANDA215177** · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2025-07-15
## Drug
- **FDA Application Number:** ANDA215177
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESCITALOPRAM OXALATE
- **Generic name:** ESCITALOPRAM
- **Active ingredients:** ESCITALOPRAM OXALATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASCENT PHARMS INC
- **Manufacturer:** Ascent Pharmaceuticals, Inc
- **First approval:** 2025-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215177)
---
*AI Analytics · CC0 1.0*